ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $9,742,000 | +19.0% | 210,500 | -9.2% | 0.13% | +21.1% |
| Q1 2017 | $8,185,000 | +541.0% | 231,800 | +127.3% | 0.11% | +581.2% |
| Q4 2016 | $1,277,000 | -9.6% | 102,000 | 0.0% | 0.02% | +6.7% |
| Q3 2016 | $1,413,000 | +40.2% | 102,000 | 0.0% | 0.02% | +50.0% |
| Q2 2016 | $1,008,000 | -41.6% | 102,000 | 0.0% | 0.01% | -23.1% |
| Q1 2016 | $1,725,000 | +244.3% | 102,000 | +353.3% | 0.01% | +333.3% |
| Q4 2015 | $501,000 | – | 22,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $99,609,000 | 22.32% |
| Bellevue Group AG | 5,465,715 | $203,160,000 | 2.81% |
| Rhenman & Partners Asset Management AB | 455,000 | $16,912,000 | 1.50% |
| Endurant Capital Management LP | 135,901 | $5,051,000 | 1.49% |
| Boxer Capital, LLC | 975,000 | $36,241,000 | 1.25% |
| DCF Advisers, LLC | 56,500 | $2,100,000 | 1.07% |
| Pentwater Capital Management LP | 2,169,022 | $80,623,000 | 1.04% |
| Nicholas Investment Partners, LP | 235,855 | $8,767,000 | 0.95% |
| Amia Capital LLP | 20,464 | $761,000 | 0.88% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,717,000 | 0.83% |